Alpha Variant Of SARS-CoV-2 Delays Immune Response Of Infected Cells

The New York Times (6/7, Zimmer) reports a new study that looked at how the Alpha variant of the novel coronavirus has become dominant in the UK and in the US. One reason for its success is that “Alpha disables the first line of immune defense in our bodi...